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Background: Carotid Duplex Ultrasonography (CDUS) is one of the non-invasive imaging modalities used to evaluate
for carotid artery stenosis. However, it is often used in patients with coronary artery disease (CAD), peripheral artery
disease (PAD), before heart surgery, syncope and non-specific neurological symptoms although its value is unclear. Our
study aimed to further investigate the yield of CDUS in these conditions.
Methods: A retrospective analysis was conducted on 827 consecutive carotid ultrasounds ordered between March
2013 and August 2013 at Newark Beth Israel Medical Center. Clinical characteristics such as age, sex, smoking status,
systemic hypertension, diabetes mellitus, CAD, PAD, carotid bruit and indications for carotid ultrasound were included.
Significant cerebrovascular disease (sCBVD) was defined as greater than or equal to 50% diameter reduction in internal
carotid arteries (ICA) or any degree of occlusion in vertebrobasilar system.
Results: Only 88 out of 827 (10.6%) patients had sCBVD. Using logistic regression analysis we identified age greater
than 65 years (OR 2.1, 95% CI 1.2 to 3.7; P = 0.006), carotid bruit (OR 7.8, 95% CI 3.6 to 16.6; P <0.001) and history of
prior carotid endarterectomy or carotid artery stenting (OR 5.8, 95% CI 2.3 to 14.8; P <0.001) as significant predictors of
sCBVD.
Conclusions: Significant carotid artery stenosis is more likely in patients 65 years and older, presence of carotid bruit
and prior CEA. On the other hand, it has low diagnostic yield in less than 65-year-old individuals, syncope and
non-focal neurological symptoms. This highlights the need for better risk prediction models in order to promote
optimal utilization.
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Carotid artery stenosis is an important cause of cervical
bruit, amaurosis fugax, acute ischemic stroke and transi-
ent ischemic attack (TIA). These patients can be evaluated
with carotid duplex ultrasonography. Prevalence of carotid
artery stenosis in the general population is 0.2% to 7.5% in
moderate (>50%) stenosis and lower 0% to 3.1% in severe
(>70%) stenosis [1]. However, only selected asymptomatic
individuals with severe carotid artery stenosis greater than
70% are shown to benefit from carotid endarterectomy
(CEA) [2]. While CEA reduces incidence of stroke [2],
routine use of CDUS has not been shown to reduce peri-
operative stroke or mortality [3]. CDUS is often used in
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unless otherwise stated.(CABG), known atherosclerosis (coronary or peripheral
artery disease), and syncope. Although studies [4,5] have
shown correlation of carotid artery disease and coronary
artery disease, its utility in asymptomatic patients is
unclear [6]. In 2011 American College of Cardiology
Foundation (ACCF) delineated recommendations for
appropriate use of CDUS [7]. Our objective is to deter-
mine the yield of CDUS and identify risk factors of sig-
nificant cerebrovascular disease (sCBVD). We also seek
to calculate prevalence of significant carotid artery disease
among appropriate and uncertain indications as per ACCF
appropriate use criteria task force. Our hypothesis is that
CDUS is over utilized for uncertain or inappropriate indi-
cations at our institution. We hope that our study helps
providers in recognizing this and thereby promote optimal
utilization of carotid ultrasound.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Study design and patients
After approval of Institutional Review Board at Newark
Beth Israel Medical Center, we included 827 carotid ultra-
sounds consecutively ordered between March 1st, 2013
and August 31st, 2013 at Newark Beth Israel Medical
Center. Baseline characteristics such as age, sex, diabetes
mellitus, systemic hypertension, coronary artery disease
(CAD), peripheral arterial disease (PAD), smoking history,
carotid bruit and indications for CDUS were abstracted
using retrospective chart review. Importantly, our data
also included a cohort of patients who underwent CDUS
before CABG (91), valvular replacement/repair (34) and
Orthotopic Heart Transplantation (25).
Study protocol
All studies were performed in vascular laboratory using
duplex scanner GE Logiq E-9 by credentialed vascular
technologists. Patients were asked to lay supine with chin
raised and head slightly turned. Imaging started with com-
mon carotid artery (CCA) in transverse position at cla-
vicular level followed by examination in a sagittal plane
utilizing gray scale. Then, spectral waveform analysis was
obtained with transducer in sagittal plane and doppler
angle kept between 45 and 60 degrees positioned in prox-
imal CCA. This procedure was repeated along entire
length of CCA and a representative spectral waveform
was recorded of the proximal, mid and distal CCA and
bulb area. Doppler samples and representative spectral
waveforms were recorded of proximal, mid and distal in-
ternal carotid artery (ICA) and proximal external carotid
artery (ECA). If any plaque was noted, waveforms were re-
corded in area proximal to plaque, at the area of plaque
and distal to the plaque. Similarly, if there was significant
stenosis waveform were recorded proximal to stenosis, at
the stenosis and distal to stenosis if they were not already
documented as per stated protocol. Finally, waveforms of
vertebral and subclavian arteries were recorded. Peak sys-
tolic velocities, end diastolic velocities, plaque description
using B-mode was also documented.
Stenosis in vertebrobasilar system or greater than 50%
ICA stenosis was considered significant cerebrovascular
disease (sCBVD) as per the Intersocietal Accreditation
Commission (IAC) vascular testing carotid stenosis inter-
pretation criteria based on Society of Radiologists in
Ultrasound Consensus Conference [8]. Based on these
guidelines less than 50% ICA stenosis was diagnosed with
peak systolic velocity (PSV) less than 125 cm/sec and no
visible plaque or intimal thickening, 50%–69% stenosis
was identified when ICA PSV was 125–230 cm/sec with
visible plaque and ICA PSV greater than 230 cm/sec along
with visible plaque and lumen narrowing was comparable
with 70% stenosis to near occlusion. Markedly narrowed
lumen was suggestive of near occlusion and no detectablelumen or flow at gray-scale was indicative of total occlu-
sion. These generalized thresholds were used to minimize
variability in reporting of degree of stenosis. All results
were read and confirmed by 2 board certified vascular sur-
geons to reduce inter-observer variability.
Statistical analysis
Statistical analysis was completed using SPSS software,
version 22.0. Continuous data was shown using median
and interquartile range (IQR) while categorical data was
shown in frequencies and percentages. Age, sex, smoking
status, CAD, PAD, systemic hypertension, diabetes melli-
tus, TIA, acute ischemic stroke, carotid bruit, cardiac sur-
gery, syncope, and prior carotid endarterectomy (CEA) or
carotid artery stenting (CAS) were fitted as independent
variables and sCBVD was fitted as a dependent variable. A
multinomial step-wise logistic regression was then per-
formed along with likelihood ratio, odds ratio and 95%
confidence intervals to determine association of various
risk factors with sCBVD. A P-value of less than 0.05 was
considered statistically significant.
Results
Out of 827 CDUS performed, significant cerebrovascular
disease (sCBVD) was found in 88 (10.6%) cases. Baseline
characteristics and demographics are shown in Table 1. 62
(7.5%) patients were found to have 50-69% ICA occlusion,
11 (1.3%) had 70-99% ICA occlusion, 3 (0.4%) patients
had near total occlusion, 10 (1.2%) patients had total ICA
occlusion and 2 (0.2%) had vertebral artery occlusion. 7
individuals with severe ICA stenosis (70-99%) underwent
carotid endarterectomy while 4 were treated with medical
therapy. Thus, 11 out of 827 (1.3%) patients had 70-99%
stenosis in which a carotid intervention was deemed
beneficial.
Yield of carotid ultrasound was different among various
indications (Table 2 and Figure 1). Prevalence of sCBVD
was higher in all appropriate use indications when
compared to uncertain use indications except in pa-
tients undergoing heart transplant (Table 2). Patients with
age ≥65 (OR 2.1, 95% CI 1.2-3.7; P = 0.006), carotid bruit
(OR 7.7, 95% CI 3.6-16.6; P <0.001) and prior carotid end-
arterectomy (CEA) or prior carotid artery stenting (CAS)
(OR 5.8, 95% CI 2.3-14.8; P <0.001) were significantly
more likely to have sCBVD (Table 3). Out of 26 patients
with previous carotid endarterectomy, sCBVD was seen in
14 patients. Among 14 cases, contralateral ICA stenosis
was seen in 11 patients with 50-69% stenosis in 3 patients,
70-99% stenosis in 5 patients and absent flow in 3 pa-
tients. Remaining 3 out of 14 patients had stenosis in ipsi-
lateral ICA. Mean peak systolic velocities (PSV) are listed
in Table 4. Average PSV was 228.9 cm/s and 556.1 cm/s
in patients with 50-69% stenosis and 70-99% stenosis
respectively.
Table 1 Baseline clinical characteristics and demographics
Variables Total sCBVD No sCBVD % sCBVD
N (%) = 827
(100)
n (%) = 88
(10.6)
n (%) = 739
(89.4)
Age
Median 67 65 67
IQR 56-77 62-82 57-77
≥ 65 481 (58.2) 66 (75.0) 415 (56.2) 13.7
< 65 346 (41.8) 22 (25.0) 324 (43.8) 6.4
Sex
Female 442 (53.4) 50 (56.8) 392 (53.0) 11.3
Male 385 (46.6) 38 (43.2) 347 (47.0) 9.9
DM 299 (36.2) 36 (40.9) 263 (35.6) 12
HTN 400 (48.4) 48 (54.5) 352 (47.6) 12
Smoker 164 (9.8) 22 (25) 142 (19.2) 13.4
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(6.4%), presenting with syncope (6.5%) non-focal neuro-
logic symptoms (6.1%) such as delirium, gait imbalance,
paresthesias and patients undergoing valvular repair or re-
placement (5.9%). Of note, sCBVD was higher (16%) in
patients undergoing Orthotopic Heart Transplantation or
Left Ventricular Assist Device placement but didn’t reach
statistical significance.Table 2 Prevalence of sCBVD in appropriate use and uncertai
Indications Total
N (%) = 827 (100)
Appropriate
Bruit 37 (4.5)
H/o CEA/CAS 26 (3.1)
Acute stroke 72 (8.7)
TIA 125 (15.1)
CAD or PAD 394 (49.6)
Uncertain
Syncope 184 (22.2)
Non-focal neurological symptoms 33 (4)
Before cardiac surgery
a. CABG 91 (11)
b. Valvular 34 (4.1)
c. OHT 25 (3)
Legend:
• sCBVD – significant cerebrovascular disease.
• H/o CEA/CAS – history of prior carotid endarterectomy or carotid artery stenting b
• CAD/PAD – Coronary Artery Disease or Peripheral Artery Disease.
• DM – Diabetes Mellitus.
• HTN – systemic hypertension.
• TIA – Transient Ischemic Attack.
• Non focal neurological symptoms include delirium, gait abnormality or paresthesia
• OHT – Orthotopic Heart Transplantation.
• CABG – Coronary Artery Bypass Grafting.Discussion
Interestingly, prevalence of severe carotid artery stenosis
(≥70%) was lower (1.3%) in our study considering it in-
cluded patients with symptomatic carotid artery disease.
This is similar to previous studies albeit in asymptomatic
patients [1,9]. Recent guidelines adopted by the ACCF
[7] and USPSTF [9] indicate that performing “screening”
CDUS in asymptomatic patients is not as useful com-
pared to symptomatic patients. Evaluation of ischemic
stroke, TIA, focal neurological symptoms, cervical bruit
as well as asymptomatic patients with known CAD, PAD
or abdominal aortic aneurysm was considered appropri-
ate indications. However syncope, planned CABG and
valvular surgery were labeled as an “uncertain” indica-
tion. Carotid intima-media thickness [6] and computer-
ized tomography guided coronary artery calcium scoring
are two of the most commonly used techniques to detect
subclinical atherosclerosis [10,11]. However, carotid du-
plex ultrasound exam does not include formal measure-
ment of carotid intimal medial thickness. In addition,
several studies support the association of CAD and ca-
rotid artery disease [4,10] as well as between PAD and
carotid artery disease [12,13]. Thus, patients with CAD
or PAD may warrant assessment of carotid artery disease
even in the absence of any focal neurological symptoms.
Carotid bruit can also signify systemic atherosclerosis
[14] and thus impart increased risk of stroke [15], TIAsn use indications
sCBVD No sCBVD % sCBVD
n (%) = 88 (10.6) n (%) = 739 (89.4)
19 (21.6) 18 (2.4) 51.4
14 (15.9) 12 (1.6) 53.8
10 (11.4) 62 (8.4) 13.9
18 (20.5) 107 (14.5) 14.4
53 (60.2) 341 (46.1) 13.5
12 (13.6) 172 (23.3) 6.5
2 (2.3) 31 (4.2) 6.1
9 (10.2) 82 (11.1) 9.9
2 (2.3) 32 (4.3) 5.9
4 (4.5) 21 (2.8) 16

















Figure 1 Percentage of sCBVD across all risk factors.
Legend: sCBVD – significant cerebrovascular disease. H/o CEA/CAS –
history of prior carotid endarterectomy or carotid artery stenting but
asymptomatic and without carotid bruit. CAD/PAD – Coronary Artery
Disease or Peripheral Artery Disease. DM – Diabetes Mellitus. HTN –
systemic hypertension. TIA – Transient Ischemic Attack.
Miscellaneous – non-focal neurological symptoms and before
cardiac surgery. OHT – Orthotopic Heart Transplantation.
Table 4 Peak systolic velocities and degree of stenosis in
88 cases with sCBVD
Stenosis PSV (cm/s) N(%)
50-69% 228.9 62 (7.5%)
70-99% 556.1 11 (1.3%)
Near occlusion Undetectable 3 (0.4%)
Total occlusion Undetectable 10 (1.2%)
Vertebral - 2 (0.2%)
Legend:
• sCBVD – significant cerebrovascular disease.
• H/o CEA/CAS – history of prior carotid endarterectomy or carotid artery
stenting but asymptomatic and without carotid bruit.
• CAD/PAD – Coronary Artery Disease or Peripheral Artery Disease.
• TIA – Transient Ischemic Attack.
• DM – Diabetes Mellitus.
• HTN – systemic hypertension.
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stroke after cardiac surgery to be about 2% in patients
undergoing CABG [17,18]. Factors such as advanced age,
presence of PAD, left main disease, diabetes mellitus,
systemic hypertension, stroke and history of previous
cerebrovascular disease could confer higher risk of peri-
operative stroke and thus suggest the need for screening
CDUS [17]. While a few studies have demonstrated cor-
relation between these risk factors and carotid artery sten-
osis ≥50% [19,20] these risk prediction models are not
well validated. Moreover, there are no randomized con-
trolled trials to support performing CEA in asymptomatic
individuals prior to vascular surgeries such as CABG andTable 3 Risk factors predictive of sCBVD using logistic
regression, odds ratio and 95% CI
Risk factors OR (Odds ratio) 95% CI interval P-value
Bruit 7.75 3.57 16.83 <0.001
H/o CEA/CAS 5.77 2.27 14.65 <0.001
Age ≥65 2.14 1.24 3.68 0.006
CAD/PAD 1.36 0.81 2.3 0.25
TIA 1.54 0.72 3.27 0.26
DM 1.28 0.78 2.12 0.34
Syncope 0.77 0.39 1.52 0.45
Cardiac surgery 0.64 0.15 2.83 0.56
Sex 0.87 0.53 1.43 0.58
Smoker 1.04 0.57 1.91 0.9
Stroke 1.05 0.41 2.71 0.92
HTN 0.99 0.58 1.67 0.96valvular repair/replacement. Routine use of CDUS before
heart transplantation is also unclear.
Several factors can lead to overutilization of carotid
ultrasound such as ease of availability, lack of conclusive
evidence supporting CDUS in asymptomatic individuals
and concerns for peri-operative stroke. To date there is no
conclusive evidence that routinely screening asymptom-
atic individuals for carotid artery stenosis reduces peri-
operative stroke. In symptomatic patients, CDUS can
detect significant carotid artery stenosis in order to re-
duce risk of peri-operative stroke via medical therapy
or surgical intervention. Three RCTs comparing carotid
endarterectomy with medical therapy showed 27% reduc-
tion (RR 0.72, 95% CI 0.58-0.90) of stroke 30 days post
CEA [21]. Recent advances in medical therapy with higher
statin use has also reduced incidence of ipsilateral stroke
to about 1.13% per year [21,22]. ACST-1 trial included pa-
tients without stroke, TIA or any other relevant neuro-
logical symptoms in past 6 months [2]. However, we
found that non-focal neurological symptoms were a com-
mon indication to perform CDUS. There is no strong evi-
dence supporting such rationale.
There are several limitations in our study. There could
be inter-observer variability among technologists. Sever-
ity of CAD could affect degree of atherosclerosis in ca-
rotid vasculature and thereby could be a significant
predictor of cerebrovascular disease. It is likely that bruit
on physical exam was under-documented or examined
only in patients with high risk for atherosclerotic cardio-
vascular disease. This could explain high yield of carotid
stenosis in such patients. Moreover, patient with less
than 50% stenosis of carotid arteries could have hetero-
geneous unstable plaque and thus could be considered
high risk for stroke. High PSV in patients with previous
CEA could be attributed to CEA however most patients
with sCBVD in this group had contralateral ICA sten-
osis. Being a single center study results need to be con-
firmed in a multi-center prospective randomized study
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though our study shows few risk predictors of sCBVD, its
accuracy needs to be studied in a validation cohort. On
the other hand, our data is different from previous studies
[17,20] as it includes a cohort of patients awaiting heart
transplantation.
Conclusions
Yield of carotid ultrasound in patients less than 65 years
age, syncope, non-focal neurological symptoms and prior
to cardiac surgeries was low. Reducing its use in low risk
patients can eliminate unnecessary use of CDUS and thus
optimize efficient utilization. On the contrary, certain
patients may have higher risk of stroke despite non-
significant carotid artery stenosis such as those with un-
stable carotid plaque. Hence, a case-by-case approach may
be prudent and CDUS may be needed in such scenar-
ios. Finally, randomized prospective study and a cost-
effectiveness analysis can provide better risk prediction
model for detecting significant carotid artery stenosis in
both high and low risk patients.
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